The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore

Human Genetics

Volumn 114, Issue 2, 2004, Pages 186-191

  Heng, Chew Kiat ^a   Lal, Suman ^a   Saha, Nilmani ^b   Low, Poh Sim ^a   Kamboh, M Ilyas ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; GLUTAMIC ACID; GLUTAMINE; LEUCINE; PROLINE; VALINE;

ALLELE; ARTICLE; ASIAN; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SINGAPORE;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FACTOR XIII; FACTOR XIIIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; SINGAPORE;

EID: 1042304292     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-1040-3     Document Type: Article

References (31)

1. Aleksic N, Ahn C, Wang YW, Juneja H, Folsom A, Boerwinkle E, Wu K (2002) Factor XIIIA Val34Leu polymorphism does not predict risk of coronary artery disease: The atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 22:348-352
2. Anwar R, Stewart AD, Miloszewki KJA, Losowsky MS (1995) Molecular basis of inherited factor XIII deficiency: Identification of multiple mutations provides insights into protein function. Br J Haematol 91:728-735
3. Anwar R, Gallivan L, Edmonds SD, Markham AF (1999) Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 93:897-905
4. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117-1122
5. Attie-Castro FA, Zago MA, Lavinha J, Elion J, Rodriguez-Delfin Guerreiro JF, Franco RF (2000) Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 84:601-603
6. Board PG, Webb GC, McKee J, Ichinose A (1998) Localization of the coagulation factor XIIIa subunit gene (F13A) to chromosome 6p24-25. Cytogenet Cell Genet 48:25-27
7. Butt C, Zheng H, Randell E, Robb D, Parfrey P, Xie Y-G (2002) Combined carrier status of prothrombin 20210A and factor XIII-A L34 alleles as a strong risk factor for myocardial infarction: Evidence of a gene-gene interaction. Blood 101:3037-3041
8. Canavy I, Henry M, Morange PE (2000) Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 83:212-216
9. Catto AJ, Kohler HP, Bannan S, Stickland M, Carter A, Grant PJ (1998) Factor XIII Val 34 Leu A novel association with primary intracerebral hemorrhage. Stroke 29:813-816
10. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ (1999) Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 93:906-908
11. Corral J, Gonza'lez-Conejero R, Iniesta JA, Riviera J, Martý'nez C, Vicente V (2000) The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85:293-297
12. Corral J, Iniesta JA, Gonza'lez-Conejero R, Villalon M, Vicente V (2001) Polymorphisms of clotting factor modify the risk for primary intracranial hemorrhage. Blood 97:2979-2982
13. Franco RF, Reitsma PH, Lourenco, D, Maffei FH, Morelli V, Tavella MH, Arau'jo AG, Piccinato CE, Zago MA (1999) Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemostasis 81:676-679
14. Franco RF, Pazin-Filho A, Tavella AH, Simöes MV, Marin-Neto JA, Zago MA (2000) Factor XIII Val34Leu and the risk of myocardial infarction. Haematologica 85:67-71
15. Fickenscher K, Aab A, Stüber W (1991) A photometric assay for blood coagulation factor XIII. Thromb Haemost 65:535-540
16. Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, Moretti M, Scapoli GL (2001) A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67:183-188
17. Hill WG, Robertson A (1968) Linkage disequilibrium in finite populations. Theor Appl Genet 38:226-231
18. Kangsadalampai S, Board PG (1998) The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:2766-2770
19. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ (1998) Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79:8-13.
20. McCormack LJ, Kain K, Catto AJ, Kohler HP, Stickland MH, Grant PJ (1998) Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost 80:523-524
21. Mimuro J, Kimura S, Aoki N (1986) Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII, its effect on fibrinolysis. J Clin Invest 77:1006-1013
22. Parzer S, Mannhalter C (1991) A rapid method for the isolation of genomic DNA from citrated whole blood. Biochem J 273:229-231
23. Reiner AP, Frank MB, Schwartz SM (2002) Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 116:376-382
24. Renner W, Köppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, Wascher TC, Pilger E (2000) Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: Common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 99:35-39
25. Saha N, Christopher E. Aston, Poh S. Low, M. Ilyas Kamboh (2000) Racial and genetic determinants of plasma factor XIII activity. Genet Epidemiol 19:440-455
26. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 65:290-297
27. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in haemostasis. J Clin Invest 69:536-542
28. Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma platelets. Molecular weights, subunit structures, proteolytic activation and cross-linking of fibrinogen and fibrin. J Biol Chem 248:1395-1407
29. Trumbo TA, Maurer MC (2000) Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardio protective effects observed with the factor XIII V34L mutation. J Biol Chem 275:20627-20631
30. Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Penttila A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A (1999) Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142:295-300
31. Webb GC, Coggan M, Ichinose A, Board PG (1989) Localization of human coagulation factor XIII B subunit to chromosome bands 1q31-32.1 and restriction fragment polymorphism of the locus. Hum Genet 81:157-60